Williams, Dillon
Leuthardt, Eric C.
Genin, Guy M.
Zayed, Mohamed
Funding for this research was provided by:
American Surgical Association Foundation
Society for Vascular Surgery Foundation
NIH/National Center for Advancing Translational Sciences (UL1TR002345)
National Science Foundation (CMMI 1548571)
Center for Innovation in Neuroscience and Technology
Article History
Received: 2 July 2020
Accepted: 4 May 2021
First Online: 9 June 2021
Competing interests
: DW has no competing interests. ECL, GMG, and MAZ have equity in the company Caeli Vascular, Inc. This company specializes in venous thrombectomy devices and does not manufacture or produce arteriovenous grafts.